Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy

BACKGROUND: Adjuvant chemotherapy (ACTx) is recommended in rectal cancer patients after preoperative chemoradiotherapy (PCRT), but its efficacy in patients in the early post-surgical stage who have a favorable prognosis is controversial. AIM: To evaluate the long-term survival benefit of ACTx in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Ye Won, Park, In Ja, Kim, Jeong Eun, Park, Jin-Hong, Lim, Seok-Byung, Kim, Chan Wook, Yoon, Yong Sik, Lee, Jong Lyul, Yu, Chang Sik, Kim, Jin Cheon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462088/
https://www.ncbi.nlm.nih.gov/pubmed/34621476
http://dx.doi.org/10.4240/wjgs.v13.i9.1000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462088/
https://www.ncbi.nlm.nih.gov/pubmed/34621476
http://dx.doi.org/10.4240/wjgs.v13.i9.1000

Ejemplares similares